Depression Relapse Predictors Study
Part of Mental health clinical trials.
This trial looks at brain and genetic markers to understand why depression returns. It is for people with major depression who are not currently taking medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be an outpatient (not in the hospital).
- You must have major depressive disorder according to standard criteria.
- You must not be taking any psychiatric medication for at least 1 week.
- You must not have other brain or mental health conditions.
- You must not have hearing loss or other physical diseases.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at adults with major depressive disorder who have responded to treatment, to find out what might predict a relapse. You will wear a wrist activity monitor and complete questionnaires.
This trial is for people with depression who have already gotten better after a 4-week course of theta burst stimulation (a type of brain stimulation). It tests two different schedules of ongoing brain stimulation (clustered vs. tapered) to see which helps prevent depression from coming back.
This study is collecting detailed information from people with depression and from healthy volunteers to better understand the biological factors involved. Participants will provide samples and complete assessments to help researchers identify new ways to diagnose and treat depression.
This study looks at treatment response markers (signs in the body) in people with major depressive disorder (MDD). It may help researchers understand who is more likely to benefit from antidepressant treatment.
This trial is looking for people with major depression to study how genes and other markers might help doctors choose the best medication. The goal is to make depression treatment more precise and effective.
This trial looks at how a specific brain receptor related to pain signals (nociceptin/orphanin FQ receptor) may be involved in depression. It may help researchers understand depression better by comparing people with current versus past (remitted) major depression.
Hear when a new Healthy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.